Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

SODIUM ACETATE

SODIUM ACETATE

Standard Dose
400MEQ/100ML (4MEQ/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary

Approval overview SODIUM ACETATE is listed in Drugs@FDA under application 214805 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient SODIUM ACETATE Form and strength SOLUTION;INTRAVENOUS - 400MEQ/100ML (4MEQ/ML) Sponsor MILLA PHARMS Submission history Latest submission status date: 2024-01-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM ACETATE is listed in Drugs@FDA under application 214805 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient SODIUM ACETATE Form and strength SOLUTION;INTRAVENOUS - 400MEQ/100ML (4MEQ/ML) Sponsor MILLA PHARMS Submission history Latest submission status date: 2024-01-22 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.